Medical Gas Therapy for Tissue, Organ, and CNS Protection: A Systematic Review of Effects, Mechanisms, and Challenges

Abstract

Gaseous molecules have been increasingly explored for therapeutic development. Here, following an analytical background introduction, a systematic review of medical gas research is presented, focusing on tissue protections, mechanisms, data tangibility, and translational challenges. The pharmacological efficacies of carbon monoxide (CO) and xenon (Xe) are further examined with emphasis on intracellular messengers associated with cytoprotection and functional improvement for the CNS, heart, retina, liver, kidneys, lungs, etc. Overall, the outcome supports the hypothesis that readily deliverable "biological gas" (CO, H 2 , H 2 S, NO, O 2 , O 3 , and N 2 O) or "noble gas" (He, Ar, and Xe) treatment may preserve cells against common pathologies by regulating oxidative, inflammatory, apoptotic, survival, and/or repair processes. Specifically, CO, in safe dosages, elicits neurorestoration via igniting sGC/cGMP/MAPK signaling and crosstalk between HO-CO, HIF-1𝜶/VEGF, and NOS pathways. Xe rescues neurons through NMDA antagonism and PI3K/Akt/HIF-1𝜶/ERK activation. Primary findings also reveal that the need to utilize cutting-edge molecular and genetic tactics to validate mechanistic targets and optimize outcome consistency remains urgent; the number of neurotherapeutic investigations is limited, without published results from large in vivo models. Lastly, the broad-spectrum, concurrent multimodal homeostatic actions of medical gases may represent a novel pharmaceutical approach to treating critical organ failure and neurotrauma.

Genetically engineered mesenchymal stem cells as a nitric oxide reservoir for acute kidney injury therapy

“…NO, the first and most well-known gaseous molecule, has been widely shown to play critical roles in a wide spectrum of physiological and pathological processes(18, 20). As a result, many kinds of NO-releasing platforms have emerged in the field of chemical materials to deliver NO in a controlled manner(18, 21). Although endogenous (enzyme and pH variations) or exogenous (light and ultrasound)-triggered NO delivery systems for controlled NO release profiles have been developed, it remains a challenge to maintain long-term NO release and eliminate immunogenicity and systemic toxicity(21, 22).…”

Biomarker‐Responsive Nanosystems for Chronic Disease Theranostics

“…Gas-responsive cancer theranostics such as gas nano generators and gas-releasing molecules in gas-sensitized therapy are attracting increasing attention in recent years because of their excellent therapeutic benefits and biosafety. [139][140][141][142] The gases include carbon monoxide (CO), [143,144] oxygen (O 2 ), [145] nitric oxide (NO), [146,147] sulfur dioxide (SO 2 ), [148] hydrogen (H 2 ), [149][150][151] hydrogen sulfide (H 2 S), [152,153] and carbon dioxide (CO 2 ), [154,155] among others. Zeng et al designed an endogenous H 2 S-responsive ratiometric FL nanoprobe (named NaYF 4 :Gd/ Yb/Er@NaYF 4 :Yb@SiO 2 @Ag) comprising Ag nanodot coated NaYF 4 :Gd/Yb/Er@NaYF 4 :Yb@SiO 2 for the in situ visualization of metformin-induced hepatotoxicity and quantitative detection of H 2 S levels in the liver region.…”

Molecular Hydrogen: From Molecular Effects to Stem Cells Management and Tissue Regeneration

“…In recent decades, medical gases have deservedly attracted much attention from specialists in the field of biomedicine. At the same time, the spectrum of gases for which biological effects have been discovered and a beneficial effects have been observed is quite wide and continues to increase [ 1 , 2 , 3 ]. Initially, the concept of “medical gases” extended only to oxygen and hyperbaric O 2 procedures, followed by the introduction of the inhalation of anesthetics and ozone into medical practice.…”